Abstract
Introduction
Plants have been an important source of medicine for thousands of years. Even today, the World Health Organization estimates that up to 80 per cent of people still rely mainly on traditional remedies such as herbs for their medicines. Plants are also the source of many modern medicines. It is estimated that approximately one quarter of prescribed drugs contain plant extracts or active ingredients obtained from or modeled on plant substances. The most popular analgesic, aspirin, was originally derived from species of Salix and Spiraea and some of the most valuable anti-cancer agents such as paclitaxel and vinblastine are derived solely from plant sources [1] [2] [3] .
Biotechnological tools are important for multiplication and genetic enhancement of the medicinal plants by adopting techniques such as in-vitro regeneration and genetic transformations. It can also be harnessed for production of secondary metabolites using plants as bioreactors. This paper reviews the achievements and advances in the application of tissue culture and genetic engineering for the in-vitro regeneration of medicinal plants from various explants and enhanced production of secondary metabolites.
In-vitro Regeneration
In-vitro propagation of plants holds tremendous potential for the production of high-quality plant-based medicines 4 . This can be achieved through different methods including micropropagation. Micropropagation has many advantages over conventional methods of vegetative propagation, which suffer from several limitations 5 . With micropropagation, the multiplication rate is greatly increased. It also permits the production of pathogen-free material. Micropropagation of various plant species, including many medicinal plants, has been reported [6] [7] [8] . Propagation from existing meristems yields plants that are genetically identical with the donor plants 9 . Plant regeneration from shoot and stem meristems has yielded encouraging results in medicinal plants like Catharanthus roseus, Cinchona ledgeriana and Digitalis spp, Rehmannia glutinosa, Rauvolfia serpentina, Isoplexis canariensis [10] [11] [12] .
Numerous factors are reported to influence the success of in-vitro propagation of different medicinal plants 9, [13] [14] [15] . . Similarly, it has been observed that cytokinin is required, in optimal quantity, for shoot proliferation in many genotypes but inclusion of low concentration of auxins along with cytokinin triggers the rate of shoot proliferation [20] [21] [22] [23] . Barna and Wakhlu has indicated that the production of multiple shoots is higher in Plantago ovata on a medium having 4-6 M kinetin along with 0.05 µM NAA
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. According to Faria and Illg, the addition of 10 µM BA along with 5 µM indole-3-acetic acid (IAA) or 5 µM NAA induces a high rate of shoot proliferation of Zingiber spectabile 25 . Faria and Illg have also shown that the number of shoots/explant depends on concentrations of the growth regulators and the particular genotypes. The nature and condition of explants has also been shown to have a significant influence on the multiplication rate of Clerodendrum colebrookianum by Mao et al.
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. Actively growing materials were more responsive to shoot induction than 
Regeneration through somatic embryogenesis
Somatic embryogenesis is a process where groups of somatic cells/tissues lead to the formation of somatic embryos which resemble the zygotic embryos of intact seeds and can grow into seedlings on suitable medium. Plant regeneration via somatic embryogenesis from single cells, that can be induced to produce an embryo and then a complete plant, has been demonstrated in many medicinal plant species. Arumugam and Bhojwani noted the development of somatic embryos from zygotic embryos of Podophyllum hexandrum on MS medium containing 2 µM BA and 0. Efficient development and germination of somatic embryos are prerequisites for commercial plantlet production. Lowering of growth regulator concentrations in culture media has improved embryo development and germination of many medicinal plants 38, 48, 49 . Germination of the somatic embryos is achievable on MS medium without the growth regulator 41, 44 . However, Arumugam and Bhojwani noted that inclusion of BA (2 µM) and gibberellic acid (GA3, 2.8 µM) in the medium stimulated embryo development of Podophyllum hexandrum, although 75% of the embryos germinated on basal MS medium devoid of growth regulator 38 . Similar results were reported on the germination of embryos of Psoralea corylifolia Further, Kunitake and Mii reported that 30-40% of somatic embryos of A. officinalis germinated after being treated with distilled water for a week; they were subsequently transferred to half-strength MS medium supplemented with 1.0 mg/L IAA, 1.0 mg/L GA3 and 1% sucrose 50 . However, the somatic embryos of Typhonium trilobatum have been germinated on MS medium supplemented with 0.01 mg/L NAA and 2% (w/v) sucrose after 2 weeks of culture 45 . When plants are regenerated and no abnormality is seen either in fertility or in alkaloid content, the materials can be stored using cryopreservation methods. Cryopreservation has been used successfully to store a range of tissue types, including meristems, anthers/pollens, embryos, calli and even protoplasts. However, the system will depend on the availability of liquid nitrogen methods.
Conservation through cryopreservation

Production of secondary metabolites from medicinal plants
Plants are the traditional source of many chemicals used as pharmaceuticals. Most valuable phytochemicals are products of plant secondary metabolism. The production of secondary metabolites in-vitro can be possible through plant cell culture 53, 54 . Successful establishment of cell lines capable of producing high yields of secondary compounds in cell suspension cultures has been reported by Zenk 55 . The accumulation of secondary products in plant cell cultures depends on the composition of the culture medium, and on environmental conditions 56 . Strategies for improving secondary products in suspension cultures, using different media for different species, have been reported by Robins 57 .
The production of secondary metabolites in plant cell suspension cultures has been reported from various medicinal plants. The production of solasodine from calli of Solanum eleagnifolium, and pyrrolizidine alkaloids from root cultures of Senecio sp. are examples 58, 59 . Since the biosynthetic efficiency of populations varies, a high yielding variety should be selected as a starting material.
The fundamental requirement in all this is a good yield of the compound, and reduced cost compared to the natural synthesis by the plants.
The bioreactor system has been applied for embryogenic and organogenic cultures of several plant species 66, 67 . Significant amounts of sanguinarine were produced in cell suspension cultures of Papaver somniferum using bioreactors 68 . Ginseng root tissue cultures in a 20 tonne bioreactor produced 500 mg/L/day; of the saponin that is considered as a very good yield Bioreactors offer optimal conditions for large-scale plant production for commercial manufacture 72 . Much progress has been achieved in the recent past on optimization of these systems for the production and extraction of valuable medicinal plant ingredients such as ginsenosides and
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shikonin. Roots cultivated in bioreactors have been found to release medicinally active compounds, including the anticancer drug isolated from various Taxus species, into the liquid media of the bioreactor which may then be continuously extracted for pharmaceutical preparations 4 . Conventional practices require the harvest of the bark of trees, all approximately 100 years old, to obtain 1 kg of the active compound taxol 73 .
Research over the last two decades has established efficient protocols for isolated cell cultures and a large-scale bioreactor system. The acceptance of this process for the industrial production of this invaluable compound has recently been established and will significantly impact the production of the tumor-inhibiting pharmaceutical 73 .
Genetic Transformation
The recent advances and developments in plant genetics and recombinant DNA technology have helped to improve and boost research into secondary metabolite biosynthesis. A major line of research has been to identify enzymes of a metabolic pathway and then manipulate these enzymes to provide better control of that pathway. Transformation is currently used for genetic manipulation of more than 120 species of at least 35 families, including the major economic crops, vegetables, ornamental, medicinal, fruit, tree and pasture plants, using Agrobacteriummediated or direct transformation methods 74 . However, Agrobacterium-mediated transformation offers several advantages over direct gene transfer methodologies (particle bombardment, electroporation, etc), such as the possibility to transfer only one or few copies of DNA fragments carrying the genes of interest at higher efficiencies with lower cost and the transfer of very large DNA fragments with minimal rearrangement [75] [76] [77] . The gram-negative soil bacteria, Agrobacterium tumefaciens, and the related species, A. rhizogenes, are causal agents of the plant diseases crown gall tumour and hairy root, respectively. These species, which belong to the Rhizobiaceae, are natural engineers that are able to transform or modify, mainly dicotyledonous plants, although there are reports on the infection of monocotyledonous plants [78] [79] [80] . Virulent strains of A. tumefaciens and A. rhizogenes contain a large megaplasmid (more than 200 kb) which play a key role in tumor induction and for this reason it was named Ti plasmid, or Ri in the case of A. rhizogenes. During infection the T-DNA, a mobile segment of Ti or Ri plasmid, is transferred to the plant cell nucleus and integrated into the plant chromosome. Agrobacterium tumefaciens transfers the T-DNA into the nucleus of infected cells where it is then stably integrated into the host genome and transcribed, causing the crown gall disease 81, 82 . T-DNA contains two types of genes: the oncogenic genes, encoding for enzymes involved in the synthesis of auxins and cytokinins and responsible for tumor formation; and the genes encoding for the synthesis of opines.
Agrobacterium rhizogenes has been used regularly for gene transfer in many dicotyledonous plants 78 . Plant infection with this bacterium induces the formation of proliferative multibranched adventitious roots at the site of infection; the so-called 'hairy roots' 83 . This infection is followed by the transfer of a portion of DNA i.e. T-DNA, known as the root inducing plasmid (Riplasmid), to the plant cell chromosomal DNA. The research is going for the application of plant transformation and genetic modification using A. rhizogenes, in order to boost production of those secondary metabolites, which are naturally synthesized in the roots of the mother plant. Transformed hairy roots mimic the biochemical machinery present and active in the normal roots, and in many instances transformed hairy roots display higher product yields.
Genetic transformation has been reported for various medicinal plants. Naina Shi and Kintzios have reported the genetic transformation of Pueraria phaseoloides with Agrobacterium rhizogenes and puerarin production in hairy roots 94 . The content of puerarin in hairy roots reached a level of 1.2 mg/g dry weight and was 1.067 times the content in the roots of untransformed plants. Thus, these transformed hairy roots have great potential as a commercially viable source of secondary metabolites.
Conclusion
Plants have been an important source of medicine for thousands of years. Medicines in common use, such as aspirin and digitalis, are derived from plants, and new transgenic varieties could be created as efficient green production lines for other pharmaceuticals as well as vaccines and anticancer drugs. Tissue culture is useful for multiplying and conserving the species, which are difficult to regenerate by conventional methods and save them from extinction. The production of secondary metabolites can be enhanced using bioreactors. Bioreactors offer a great hope for the large-scale synthesis of therapeutically active compounds in medicinal plants. Since the biosynthetic efficiency of populations varies, a high yielding variety is recommended as a starting material. Genetic transformation may provide increased and efficient system for in-vitro production of secondary metabolites. The improved in-vitro plant cell culture systems have potential for commercial exploitation of secondary metabolites. Tissue culture protocols have been developed for several plants but there are many other species, which are over exploited in pharmaceutical industries and need conservation.
